AEON Biopharma, Inc. (AEON)
AEON Biopharma was planning to go public, but the IPO has been withdrawn.
Stock Price: $14.00 - $16.00
Current IPO price range
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 |
|---|---|---|
| Revenue
|
2.52 | 3.36 |
| Revenue Growth (YoY)
|
-24.99% | - |
| Cost of Revenue
|
- | 0 |
| Gross Profit
|
2.52 | 3.36 |
| Selling, General & Admin
|
11.59 | 46.04 |
| Research & Development
|
7.32 | 4.81 |
| Other Operating Expenses
|
0 | 6.47 |
| Operating Expenses
|
18.91 | 57.32 |
| Operating Income
|
-16.39 | -53.97 |
| Interest Expense / Income
|
0 | 4.46 |
| Other Expense / Income
|
16.52 | -204.09 |
| Pretax Income
|
-32.91 | 145.67 |
| Income Tax
|
- | -14.65 |
| Net Income
|
-32.91 | 160.32 |
| Net Income Common
|
-32.91 | 172.92 |
| Gross Margin
|
100.00% | 99.97% |
| Operating Margin
|
-650.83% | -1607.57% |
| Profit Margin
|
-1307.11% | 5151.03% |
| Free Cash Flow Margin
|
-375.74% | -1382.75% |
| Effective Tax Rate
|
0.00% | -10.05% |
| EBITDA
|
-32.91 | 151.62 |
| EBITDA Margin
|
-1307.07% | 4516.59% |
| Depreciation & Amortization
|
- | 1.5 |
| EBIT
|
-32.91 | 150.13 |
| EBIT Margin
|
-1307.07% | 4472.06% |
Source: IPO financials are sourced from
S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).